InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Lenz Robert A.. Insider active across 2 companies, notably Neumora Therapeutics, Inc.. Aggregated, 7 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €752k. History available since 14 September 2023. The latest transaction was filed on 18 February 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Lenz Robert A. is Head of R&D at Neumora Therapeutics, Inc. (XNAS). He has 6 filings in total, and across the recent filings observed from 2023-09-18 to 2025-02-20, they are sales totaling EUR 752282.